95 related articles for article (PubMed ID: 6325754)
1. [In vivo antibacterial activity of cefoperazone in intraperitoneal infections in mice].
Minami S; Yotsuji A; Nakashima H; Watanabe Y; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3444-9. PubMed ID: 6325754
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of cefoperazone].
Watanabe Y; Minami S; Yotsuji A; Araki H; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3437-43. PubMed ID: 6609251
[TBL] [Abstract][Full Text] [Related]
3. [In vivo effects of cefoperazone in local infection].
Kumano K; Nishida N; Hayashi T; Kasuga C; Watanabe Y; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3450-5. PubMed ID: 6325755
[TBL] [Abstract][Full Text] [Related]
4. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
6. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
Wise R; Andrews JM; Bedford KA
J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
[TBL] [Abstract][Full Text] [Related]
7. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
Kawagoe M; Narushima K; Kitani A; Shibuya T; Hara M; Hosono K; Shitara M
Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
Aksoy AM; Ozsan M; Ural O; Ekmen H
Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
[TBL] [Abstract][Full Text] [Related]
13. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
14. [Basic and clinical studies on cefotiam in the field of obstetrics and gynecology].
Ninomiya K; Ohbayashi F; Hasegawa Y; Hamaya K; Nishio T
Jpn J Antibiot; 1982 Dec; 35(12):2812-21. PubMed ID: 6304363
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of cephems: cefoperazone in the treatment of postoperative infections].
Idegami K; Mori K; Ikei S; Yamane T; Katabuchi S; Ichihara T; Sakamoto K; Morinaga H; Kanamitsu T; Beppu T
Jpn J Antibiot; 1984 May; 37(5):823-8. PubMed ID: 6481956
[TBL] [Abstract][Full Text] [Related]
16. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
17. [Cefoperazone concentration in infected tissues and clinical effect for patients with peritonitis (author's transl)].
Hashimoto I; Sawada Y; Nakamura T; Mikami J; Hirasawa S; Abe H; Bekki E; Watanabe Y
Jpn J Antibiot; 1980 Dec; 33(12):1301-5. PubMed ID: 6454013
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial activity of cefotiam against clinical isolates in the field of obstetrics and gynecology].
Deguchi K
Jpn J Antibiot; 1983 Apr; 36(4):678-88. PubMed ID: 6308295
[TBL] [Abstract][Full Text] [Related]
19. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Abe T; Sato Y; Sei M
Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
Watanabe T; Kazuno Y; Hirano F; Inouye S; Nishino T
Drugs Exp Clin Res; 1985; 11(11):781-6. PubMed ID: 3841789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
